Ju et al. (2020a) have illustrated that erythroid 2 like 2 (NFE2L2) expression is positively associated with immune infiltration, which hints a more favorable prognosis in brain lower grade glioma. The gene discussed is NFE2L2; the disease is central nervous system cancer.